Cargando…
Metallothioneins in Failure of Dental Implants and Periodontitis Down Syndrome Patients
Background: Sometimes dental implants seem to be the only therapeutic alternative for the oral rehabilitation of patients with Down syndrome, given that they usually lose all their teeth early due to suffering aggressive periodontitis and they do not usually have the skills required to wear removabl...
Autores principales: | Baus-Domínguez, Maria, Gómez-Díaz, Raquel, Corcuera-Flores, Jose-Ramón, Torres-Lagares, Daniel, Ruiz-Villandiego, José-Cruz, Machuca-Portillo, Guillermo, Gutiérrez-Pérez, José-Luis, Serrera-Figallo, María-Angeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770985/ https://www.ncbi.nlm.nih.gov/pubmed/31540037 http://dx.doi.org/10.3390/genes10090711 |
Ejemplares similares
-
Metallothioneins in Dental Implant Treatment Failure and Periodontitis in Patients with Down’s Syndrome: Validation of Results
por: Baus-Domínguez, María, et al.
Publicado: (2022) -
Using Genetics in Periodontal Disease to Justify Implant Failure in Down Syndrome Patients
por: Baus-Domínguez, Maria, et al.
Publicado: (2020) -
Retrospective Case-Control Study Genes Related to Bone Metabolism That Justify the Condition of Periodontal Disease and Failure of Dental Implants in Patients with down Syndrome
por: Baus-Domínguez, María, et al.
Publicado: (2023) -
Differential Expression of Inflammation-Related Genes in Down Syndrome Patients with or without Periodontal Disease
por: Baus-Domínguez, M., et al.
Publicado: (2019) -
Cardiovascular effect of dental anesthesia with articaine (40 mg with epinefrine 0,5 mg % and 40 mg with epinefrine 1 mg%) versus mepivacaine (30mg and 20 mg with epinefrine 1 mg%) in medically compromised cardiac
patients: A cross-over, randomized, single blinded study
por: Torres-Lagares, Daniel, et al.
Publicado: (2012)